Thursday, December 18, 2014
Go to Market Reports.com
Live Cell Multiplex Assay
Medical Affairs at the Centre of Life Sciences Innovation
Metal Filter Products and the LC System
Microarray Platform Comparisons – Commentary on Barnes et al. (2005)
Multiflux™ Overcoming the Challenge of Reliable Multi-Way Fluidic Conn
Next-Generation Data Storage
Next-generation sequencing of highly multiplexed samples: the NuGEN En
NuGEN Technologies, Inc.
NonClinical Dose Formulation Analysis Method Validation and Sample Ana
Novel Plasticware for Three-Dimensional (3D) Cell Co-culture
showing results 55 to 63 of 110
Researchers Identify Non-Gluten Proteins as Targets of Immune Response to Wheat in Celiac Disease
The results were reported online in the Journal of Proteome Research.
New Research Unlocks a Mystery of Albinism
A team led by Brown University biologists has discovered the way in which a specific genetic mutation appears to lead to the lack of melanin production underlying a form of albinism.
Altered white-blood-cell motion in burn patients may warn of infection.
Study Finds Genetic Clue To Menopause-Like Condition In Young Women
NIH-funded research may also contribute to understanding normal menopause.
Stem Cells Faulty In Duchenne Muscular Dystrophy
In a mouse model of Duchenne muscular dystrophy, muscle stem cells express connective-tissue genes associated with fibrosis and muscle weakness, according to a new study.
How Breast Cancer Cells Break Free To Spread In The Body
Analysis of the downstream signaling pathways of a gene called SNAIL could be used to identify potential targets for scientists who are looking for ways to block or slow metastasis.
Multiple Allergic Reactions Traced To Single Protein
Points to new strategy to reduce allergic responses to many medications.
Cutting Out the Cellular Middleman
New technology directly reprograms skin fibroblasts for a new role.
Therapeutic Strategy May Treat a Childhood Neurological Disorder
Researchers have identified a possible therapy to treat neurofibromatosis type 1 or NF1.
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Advertise On This Site
Terms & Conditions
©2014 Technology Networks
, all rights reserved.